PDCD1 and neoplasm: Whereas only a small amount of NXS2 tumor cell-specific IgG1 and IgG2a antibodies were detected in tumor-vaccinated mice receiving PBS or Pd-1 inhibitory antibody alone, SUREK-only treated mice developed a higher amount of IgG1 levels (Figures 5B, C).